Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment-Comparison with Stage III Disease

In patients with oligometastatic NSCLC, a cT3-cT4 primary tumor or an cN2/cN3 lymph node status was reported to be associated with unfavorable outcome. The aim of this study was to assess the importance of definitive or neoadjuvant thoracic radiochemotherapy for long-term outcome of these patients i...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancers 2024-03, Vol.16 (6), p.1174
Hauptverfasser:	Guberina, Maja, Pöttgen, Christoph, Guberina, Nika, Hoffmann, Christian, Wiesweg, Marcel, Richlitzki, Cedric, Metzenmacher, Martin, Aigner, Clemens, Bölükbas, Servet, Gauler, Thomas, Eberhardt, Wilfried E E, Forsting, Michael, Herrmann, Ken, Theegarten, Dirk, Darwiche, Kaid, Jendrossek, Verena, Stuschke, Martin, Schuler, Martin
Format:	Artikel
Sprache:	eng
Schlagworte:	Cancer Cancer therapies Care and treatment Chemoradiotherapy Chemotherapy Comorbidity Computed tomography Drug dosages Drug therapy Immunotherapy Interdisciplinary aspects Ipilimumab Lung cancer Lung cancer, Non-small cell Lung cancer, Small cell Lymph nodes Lymphatic system Medical prognosis Metastases Metastasis Mutation Next-generation sequencing Non-small cell lung carcinoma Patient outcomes Patients PD-L1 protein PET imaging Prognosis Radiation therapy Radiotherapy Small cell lung carcinoma Surgery Thoracic surgery Thorax Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!